Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Apremilast may help treat hair loss in alopecia areata.

Antizyme slows skin tumor growth by reducing cell growth in mice.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Oral baricitinib is effective and safe for treating alopecia areata.

Blocking JAK-STAT signaling can lead to hair growth.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Specific miRNA profiles can help diagnose and treat alopecia areata.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

The treatments stopped hair regrowth in mice.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Baricitinib was effective in treating both early and late onset alopecia areata.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.